Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China · Delayed Price · Currency is CNY 13.44
+0.50 (3.86%)
Nov 13, 2026, 3:04 PM CST
SHE:300246 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 362.7 | 676.95 | 466.39 | 498.72 | 437.03 | 336.55 |
Short-Term Investments | - | - | 263.97 | 322.21 | 342.83 | - |
Trading Asset Securities | 26.02 | - | - | - | - | - |
Cash & Short-Term Investments | 388.72 | 676.95 | 730.35 | 820.93 | 779.86 | 336.55 |
Cash Growth | -41.70% | -7.31% | -11.03% | 5.27% | 131.72% | -30.33% |
Accounts Receivable | 243.21 | 246.69 | 262.44 | 261.25 | 297.24 | 232.03 |
Other Receivables | 8.83 | 9.97 | 54.72 | 27.59 | 25.22 | 26.26 |
Receivables | 252.04 | 256.67 | 317.16 | 288.84 | 322.46 | 258.29 |
Inventory | 302.33 | 287.82 | 232.07 | 220.37 | 200.57 | 193.5 |
Other Current Assets | 143.41 | 54.2 | 54.1 | 41.26 | 33 | 41.41 |
Total Current Assets | 1,086 | 1,276 | 1,334 | 1,371 | 1,336 | 829.76 |
Property, Plant & Equipment | 944.89 | 957.12 | 911.18 | 888.73 | 737.85 | 584.72 |
Long-Term Investments | 26.14 | 27.51 | 13.84 | 8.53 | 8.69 | 9.83 |
Goodwill | 15.49 | 15.49 | 25.15 | 40.67 | 127.13 | 127.13 |
Other Intangible Assets | 102.6 | 104.36 | 101.63 | 98.08 | 94.51 | 90.51 |
Long-Term Accounts Receivable | - | - | 4.12 | 5.59 | - | - |
Long-Term Deferred Tax Assets | 50.31 | 40.65 | 29.19 | 18.13 | 25 | 10.48 |
Long-Term Deferred Charges | 34.84 | 42.56 | 39.81 | 40.85 | 25.91 | 31.85 |
Other Long-Term Assets | 83.64 | 58.97 | 40.21 | 62.43 | 83.97 | 35.24 |
Total Assets | 2,344 | 2,522 | 2,499 | 2,534 | 2,439 | 1,720 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 323.51 | 224.01 | 206.49 | 246.8 | 221.26 | 178.44 |
Accrued Expenses | 14.5 | 24.73 | 43.5 | 38.87 | 49.57 | 37.35 |
Short-Term Debt | 122.8 | 133.32 | 188.14 | 220.41 | 132.64 | 130.66 |
Current Portion of Long-Term Debt | 99.32 | 264.28 | 40.7 | 50.37 | 14.55 | 8.06 |
Current Portion of Leases | - | - | 6.65 | 6.45 | 5.95 | 4.47 |
Current Income Taxes Payable | 5.46 | 4.47 | 1.98 | 3.08 | 3.98 | 3.37 |
Current Unearned Revenue | 68.9 | 49.15 | 43.75 | 69.39 | 76.01 | 48.08 |
Other Current Liabilities | 92.22 | 102.59 | 144.61 | 135.34 | 99.43 | 86.77 |
Total Current Liabilities | 726.72 | 802.54 | 675.82 | 770.7 | 603.39 | 497.2 |
Long-Term Debt | 253.45 | 306.89 | 388.05 | 284.16 | 252.97 | 205.21 |
Long-Term Leases | 21.17 | 20.32 | 22.19 | 23.61 | 21.46 | 8.12 |
Long-Term Unearned Revenue | 175.11 | 167.89 | 106.94 | 50.3 | 45.38 | 9.32 |
Long-Term Deferred Tax Liabilities | 11.65 | 11.44 | 14.72 | 14.87 | 13.48 | 7.25 |
Other Long-Term Liabilities | - | 1.04 | - | 1.81 | - | 0.03 |
Total Liabilities | 1,188 | 1,310 | 1,208 | 1,145 | 936.68 | 727.13 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 264.76 | 264.58 | 264.58 | 264.58 | 175.79 | 146.09 |
Additional Paid-In Capital | 465.86 | 408.11 | 408.04 | 408.03 | 504.38 | - |
Retained Earnings | 374.01 | 430.53 | 513.04 | 584.48 | 684.82 | 698.15 |
Treasury Stock | -20.01 | -20.01 | -20.01 | - | - | - |
Comprehensive Income & Other | -0.84 | 54.33 | 53.04 | 53.81 | 51.09 | 49.64 |
Total Common Equity | 1,084 | 1,138 | 1,219 | 1,311 | 1,416 | 893.89 |
Minority Interest | 72.52 | 74.65 | 72.43 | 78.05 | 86.17 | 98.49 |
Shareholders' Equity | 1,156 | 1,212 | 1,291 | 1,389 | 1,502 | 992.38 |
Total Liabilities & Equity | 2,344 | 2,522 | 2,499 | 2,534 | 2,439 | 1,720 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 496.75 | 724.8 | 645.72 | 584.99 | 427.57 | 356.52 |
Net Cash (Debt) | -108.03 | -47.86 | 84.63 | 235.94 | 352.29 | -19.97 |
Net Cash Growth | - | - | -64.13% | -33.03% | - | - |
Net Cash Per Share | -0.41 | -0.18 | 0.32 | 0.89 | 1.35 | -0.09 |
Filing Date Shares Outstanding | 264.91 | 263.9 | 261.6 | 264.58 | 263.68 | 262.22 |
Total Common Shares Outstanding | 264.91 | 263.9 | 261.6 | 264.58 | 263.68 | 219.14 |
Working Capital | 359.78 | 473.1 | 657.87 | 600.7 | 732.5 | 332.56 |
Book Value Per Share | 4.09 | 4.31 | 4.66 | 4.95 | 5.37 | 4.08 |
Tangible Book Value | 965.69 | 1,018 | 1,092 | 1,172 | 1,194 | 676.25 |
Tangible Book Value Per Share | 3.65 | 3.86 | 4.17 | 4.43 | 4.53 | 3.09 |
Buildings | - | - | 582.36 | 308.84 | 244.21 | 216.58 |
Machinery | - | - | 448.39 | 418.44 | 398.3 | 361.28 |
Construction In Progress | - | - | 127.92 | 365.74 | 263.45 | 155.7 |